Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The… Read more
Market Cap & Net Worth: Guangzhou Improve Med Instrument (300030)
Guangzhou Improve Med Instrument (SHE:300030) has a market capitalization of $346.39 Million (CN¥2.54 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #14165 globally and #3693 in its home market, demonstrating a -1.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou Improve Med Instrument's stock price CN¥8.22 by its total outstanding shares 309187315 (309.19 Million).
Guangzhou Improve Med Instrument Market Cap History: 2015 to 2026
Guangzhou Improve Med Instrument's market capitalization history from 2015 to 2026. Data shows change from $813.07 Million to $346.39 Million (-8.45% CAGR).
Guangzhou Improve Med Instrument Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou Improve Med Instrument's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.40x
Guangzhou Improve Med Instrument's market cap is 0.40 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $813.07 Million | $545.35 Million | $39.84 Million | 1.49x | 20.41x |
| 2016 | $575.84 Million | $517.10 Million | $30.48 Million | 1.11x | 18.89x |
| 2017 | $355.16 Million | $549.65 Million | $11.16 Million | 0.65x | 31.83x |
| 2018 | $215.19 Million | $549.96 Million | -$136.80 Million | 0.39x | N/A |
| 2019 | $297.92 Million | $575.06 Million | $26.02 Million | 0.52x | 11.45x |
| 2020 | $513.95 Million | $919.23 Million | $162.52 Million | 0.56x | 3.16x |
| 2021 | $446.27 Million | $799.83 Million | $18.57 Million | 0.56x | 24.03x |
| 2022 | $290.34 Million | $710.77 Million | -$193.29 Million | 0.41x | N/A |
| 2023 | $326.58 Million | $644.62 Million | -$63.20 Million | 0.51x | N/A |
| 2024 | $232.61 Million | $581.33 Million | -$117.90 Million | 0.40x | N/A |
Competitor Companies of 300030 by Market Capitalization
Companies near Guangzhou Improve Med Instrument in the global market cap rankings as of March 19, 2026.
Key companies related to Guangzhou Improve Med Instrument by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Guangzhou Improve Med Instrument Historical Marketcap From 2015 to 2026
Between 2015 and today, Guangzhou Improve Med Instrument's market cap moved from $813.07 Million to $ 346.39 Million, with a yearly change of -8.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥346.39 Million | +11.68% |
| 2025 | CN¥310.15 Million | +33.33% |
| 2024 | CN¥232.61 Million | -28.77% |
| 2023 | CN¥326.58 Million | +12.48% |
| 2022 | CN¥290.34 Million | -34.94% |
| 2021 | CN¥446.27 Million | -13.17% |
| 2020 | CN¥513.95 Million | +72.51% |
| 2019 | CN¥297.92 Million | +38.45% |
| 2018 | CN¥215.19 Million | -39.41% |
| 2017 | CN¥355.16 Million | -38.32% |
| 2016 | CN¥575.84 Million | -29.18% |
| 2015 | CN¥813.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Guangzhou Improve Med Instrument was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $346.39 Million USD |
| MoneyControl | $346.39 Million USD |
| MarketWatch | $346.39 Million USD |
| marketcap.company | $346.39 Million USD |
| Reuters | $346.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.